{
  "id": "6419cd02690f196b5100003a",
  "type": "summary",
  "question": "What are Luminopsins?",
  "ideal_answer": "Luminopsins (LMOs) are chimeric proteins consisting of a luciferase fused to an opsin that provides control of neuronal activity.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/31670406",
    "http://www.ncbi.nlm.nih.gov/pubmed/28862809",
    "http://www.ncbi.nlm.nih.gov/pubmed/30152529",
    "http://www.ncbi.nlm.nih.gov/pubmed/26733686",
    "http://www.ncbi.nlm.nih.gov/pubmed/35836081",
    "http://www.ncbi.nlm.nih.gov/pubmed/35126293",
    "http://www.ncbi.nlm.nih.gov/pubmed/26399324",
    "http://www.ncbi.nlm.nih.gov/pubmed/30957296",
    "http://www.ncbi.nlm.nih.gov/pubmed/34281270",
    "http://www.ncbi.nlm.nih.gov/pubmed/29577367"
  ],
  "snippets": [
    {
      "text": "Luminopsins (LMOs) are chimeric proteins consisting of a luciferase fused to an opsin that provide control of neuronal activity",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31670406",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Previous work has demonstrated that fusion of a luciferase to an opsin, to create a luminescent opsin or luminopsin",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28862809",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "luminopsins, fusion proteins of light-generating luciferase and light-sensing ion channels that could be used to increase neuronal excitability if exposed to a suitable substrate",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34281270",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BL-OG is realized through opsin-luciferase fusion proteins called luminopsins (LMOs)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35836081",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Luminopsins are fusion proteins of luciferase and opsin that allow interrogation of neuronal circuits at different temporal and spatial resolutions by choosing either extrinsic physical or intrinsic biological light for its activation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26733686",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Luminopsins (LMOs) are chimeric proteins consisting of a luciferase fused to an opsin that provide control of neuronal activity, allowing for less cumbersome and less invasive optogenetic manipulation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31670406",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This is commonly achieved by utilizing a luminopsin (LMO), a fusion protein of a light-emitting luciferase tethered to a light-sensing opsin.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30152529",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Previous work has demonstrated that fusion of a luciferase to an opsin, to create a luminescent opsin or luminopsin, provides a genetically encoded means of manipulating neuronal activity via both chemogenetic and optogenetic approaches.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28862809",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We have bypassed the challenges of external light delivery by directly coupling a bioluminescent light source (a genetically encoded luciferase) to an inhibitory opsin, which we term an inhibitory luminopsin (iLMO).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26399324",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A non-invasive and highly specific approach to neuronal stimulation is bioluminescent-optogenetics (BL-OG), where genetically expressed light emitting luciferases are tethered to light sensitive channelrhodopsins (luminopsins, LMO); neurons are activated by the addition of the luciferase substrate coelenterazine (CTZ).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35126293",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We generated a neuronal precursor cell line expressing luminopsin 3 (LMO3), a luciferase-channelrhodopsin fusion protein, which responds to the luciferase substrate coelenterazine (CTZ) with emission of blue light that in turn activates the opsin.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29577367",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Thus, although preserving the ability to be activated by external light sources, LMOs expand the use of optogenetics by making the same opsins accessible to noninvasive, chemogenetic control, thereby allowing the same probe to manipulate neuronal activity over a range of spatial and temporal scales.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26733686",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BL-OG is realized through opsin-luciferase fusion proteins called luminopsins (LMOs).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35836081",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We have previously addressed these challenges by employing bioluminescence and have created a new line of opto-chemogenetic probes termed luminopsins by fusing light-sensing opsins with light-emitting luciferases.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30957296",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}